Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Associations between Vascular Biology and Hodgkin’s Lymphoma: An Overview
Authors
Keywords
-
Journal
Cancers
Volume 15, Issue 21, Pages 5299
Publisher
MDPI AG
Online
2023-11-06
DOI
10.3390/cancers15215299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRNA in the Context of Protein Replacement Therapy
- (2023) Theofanis Vavilis et al. Pharmaceutics
- Venous thromboembolism in viral diseases: A comprehensive literature review
- (2023) Nasibeh Zerangian et al. Health Science Reports
- Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review
- (2023) Qasem Al-Tashi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction
- (2023) Tong Li et al. SEMINARS IN CANCER BIOLOGY
- The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression
- (2023) Mengyuan Li et al. Frontiers in Immunology
- Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma
- (2023) Locke J. Bryan et al. JAMA Oncology
- Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
- (2023) Bilal A Siddiqui et al. Journal for ImmunoTherapy of Cancer
- Vascular Growth in Lymphomas: Angiogenesis and Alternative Ways
- (2023) Domenico Ribatti et al. Cancers
- The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy
- (2023) Roberto Tamma et al. Cancers
- Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis
- (2023) Haijiao Jing et al. Cancers
- Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
- (2023) Alessandro Cellini et al. Frontiers in Oncology
- The Role of Extracellular Vesicles in the Pathogenesis of Hematological Malignancies: Interaction with Tumor Microenvironment; a Potential Biomarker and Targeted Therapy
- (2023) Kaushik Das et al. Biomolecules
- Tumor-associated macrophages: Potential therapeutic targets and diagnostic markers in cancer
- (2023) Junyang Song et al. PATHOLOGY RESEARCH AND PRACTICE
- Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy
- (2023) Devesh Aggarwal et al. Frontiers in Immunology
- The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment
- (2023) Adrian Vasile Dumitru et al. Cells
- The Emerging Role of CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
- (2022) Jeremy A. Meier et al. Journal of Personalized Medicine
- A review of pathobiology and therapies for classic Hodgkin lymphoma
- (2022) Maliha Khan et al. BLOOD REVIEWS
- Vascular Permeability in Diseases
- (2022) Jean-Luc Wautier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis
- (2022) Junjie Huang et al. Journal of Hematology & Oncology
- Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin’s lymphoma: a phase II, non-randomized controlled trial
- (2022) Jessica Hochberg et al. Journal for ImmunoTherapy of Cancer
- The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good
- (2022) Victoria Menéndez et al. Cancers
- Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
- (2022) Alicia Cristina Peña-Romero et al. Cancers
- Liposomal doxorubicin supercharge‐containing front‐line treatment in patients with advanced‐stage diffuse large B‐cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single‐centre phase II study
- (2022) Marco Picardi et al. BRITISH JOURNAL OF HAEMATOLOGY
- AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial
- (2022) Stephanie Sasse et al. LEUKEMIA & LYMPHOMA
- Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
- (2022) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Updates in the Role of Checkpoint Inhibitor Immunotherapy in Classical Hodgkin’s Lymphoma
- (2022) Shazia Nakhoda et al. Cancers
- Metabolism and polarization regulation of macrophages in the tumor microenvironment
- (2022) Jia Wang et al. CANCER LETTERS
- JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO)
- (2022) Sarah Gillessen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Tumor-associated macrophages in lymphoma: From mechanisms to therapy
- (2022) Xingfang Xiong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin’s Lymphoma
- (2022) Sharon M. Castellino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing the TME to improve the efficacy of cancer therapy
- (2022) Maria Teresa Bilotta et al. Frontiers in Immunology
- Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL
- (2022) Mahdi Nohtani et al. Cancers
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
- (2022) Kun Cheng et al. Cancer Communications
- BCL-2 protein family: attractive targets for cancer therapy
- (2022) Deeksha Kaloni et al. APOPTOSIS
- Focus on mast cells in the tumor microenvironment: Current knowledge and future directions
- (2022) Saimeng Shi et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors
- (2022) Hamidreza Zalpoor et al. Cell Communication and Signaling
- The mechanism underlying ICAM-1 and E-selectin-mediated hypertriglyceridemic pancreatitis-associated lung injury
- (2022) Rong Yu et al. MOLECULAR IMMUNOLOGY
- Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
- (2022) Alex F Herrera et al. Lancet Haematology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular biology of Hodgkin lymphoma
- (2021) Marc A. Weniger et al. LEUKEMIA
- Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
- (2021) Rangarirai Makuku et al. Journal of Immunology Research
- Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma
- (2021) Eline A. M. Zijtregtop et al. Cancers
- Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
- (2021) Suah Yang et al. BIOMATERIALS
- Assessment of endothelial progenitor cells, VEGF-A and SDF-1α in Hodgkin's lymphoma
- (2021) Jan Filipiak et al. BLOOD COAGULATION & FIBRINOLYSIS
- Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: a comprehensive review
- (2021) Ke‐Tao Jin et al. CANCER SCIENCE
- Neoantigen: A New Breakthrough in Tumor Immunotherapy
- (2021) Zheying Zhang et al. Frontiers in Immunology
- Molecular profiling of follicular fluid miRNAs in young women affected by Hodgkin Lymphoma
- (2021) Angela Caponnetto et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Phase II single-arm study of brentuximab vedotin in Chinese patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large cell lymphoma
- (2021) Yuqin Song et al. Expert Review of Hematology
- The Role of Tumor-Associated Macrophages in Hematologic Malignancies
- (2021) Emanuele Cencini et al. Cancers
- Inflammation in Asthma Pathogenesis: Role of T cells, Macrophages, Epithelial Cells and Type 2 Inflammation
- (2021) Amina Alobaidi et al. Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry
- Preclinical pharmacology modeling of chimeric antigen receptor T therapies
- (2021) Rajendra Kumari et al. CURRENT OPINION IN PHARMACOLOGY
- Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma
- (2021) Maria A. Garcia-Marquez et al. LEUKEMIA
- Loss of function mutations of BCOR in classical Hodgkin lymphoma
- (2021) Maciej Giefing et al. LEUKEMIA & LYMPHOMA
- Immunotherapy for cancer: effects of iron oxide nanoparticles on polarization of tumor-associated macrophages
- (2021) Camila Sales Nascimento et al. Nanomedicine
- Author Correction: Hodgkin lymphoma
- (2021) Joseph M. Connors et al. Nature Reviews Disease Primers
- Approaches of the Innate Immune System to Ameliorate Adaptive Immunotherapy for B-Cell Non-Hodgkin Lymphoma in Their Microenvironment
- (2021) Takashi Watanabe Cancers
- Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations
- (2021) Artem Gusak et al. Cancers
- Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphoma
- (2021) Timothy J. Voorhees et al. Blood Advances
- Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
- (2021) Pier Luigi Zinzani et al. Blood Advances
- Synthetic mRNA – emerging new class of drug for tissue regeneration
- (2021) Elizabeth Rosado Balmayor CURRENT OPINION IN BIOTECHNOLOGY
- A Novel Cytological Model of B-Cell/Macrophage Biphenotypic Cell Hodgkin Lymphoma in Ganp-Transgenic Mice
- (2020) Sakai et al. Cancers
- Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
- (2020) Brooke Benner et al. Drug Design Development and Therapy
- Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma
- (2020) Kristiina Karihtala et al. Cancers
- Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
- (2020) Carlos A. Ramos et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome
- (2020) Laura Werner et al. Scientific Reports
- Regulation of glycolysis by the hypoxia‐inducible factor (HIF): implications for cellular physiology
- (2020) S. J. Kierans et al. JOURNAL OF PHYSIOLOGY-LONDON
- Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth
- (2020) Lutz Menzel et al. Frontiers in Immunology
- Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in Hodgkin lymphoma
- (2020) Naike Casagrande et al. CANCER LETTERS
- Tumor-associated macrophages: role in cancer development and therapeutic implications
- (2019) Arash Salmaninejad et al. CELLULAR ONCOLOGY
- Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation
- (2019) Haitham Abdelhakim et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma
- (2019) Paul G. Murray et al. BLOOD
- Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma
- (2019) Junko Yamaguchi et al. LEUKEMIA & LYMPHOMA
- Cancer and the Immune System: The History and Background of Immunotherapy
- (2019) Maura Abbott et al. Seminars in Oncology Nursing
- Immune modulation by mesenchymal stem cells
- (2019) Wei Jiang et al. CELL PROLIFERATION
- Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma
- (2019) Eleonora Calabretta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epidemiology and Etiology of Leukemia and Lymphoma
- (2019) Jordan A. Baeker Bispo et al. Cold Spring Harbor Perspectives in Medicine
- Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies
- (2019) Amy J. Petty et al. Cells
- Applications and explorations of CRISPR/Cas9 in CAR T-cell therapy
- (2019) Chenggong Li et al. Briefings in Functional Genomics
- Primary and acquired resistance mechanisms to immune checkpoint inhibition in Hodgkin lymphoma
- (2019) Johanna Veldman et al. CANCER TREATMENT REVIEWS
- Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors
- (2019) Yoshie Kametani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
- (2018) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling
- (2018) Liang Luo et al. Biomed Research International
- PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy
- (2018) Fatemeh K. Dermani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Microenvironment Cell Contribution to Lymphoma Immunity
- (2018) Deepika Kumar et al. Frontiers in Oncology
- CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
- (2018) Naike Casagrande et al. HAEMATOLOGICA
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical and immunological responses after CD30-specific chimeric antigen receptor–redirected lymphocytes
- (2017) Carlos A. Ramos et al. JOURNAL OF CLINICAL INVESTIGATION
- Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
- (2017) Sagun Goyal et al. LEUKEMIA & LYMPHOMA
- Role of the tumor microenvironment in regulating apoptosis and cancer progression
- (2016) Katherine Yaacoub et al. CANCER LETTERS
- Microenvironmental interactions in classical Hodgkin lymphoma and their role in promoting tumor growth, immune escape and drug resistance
- (2016) Donatella Aldinucci et al. CANCER LETTERS
- The Future of Vascular Biology and Medicine
- (2016) Scott Kinlay et al. CIRCULATION
- Autologous T Cells Expressing CD30 Chimeric Antigen Receptors for Relapsed or Refractory Hodgkin Lymphoma: An Open-Label Phase I Trial
- (2016) Chun-Meng Wang et al. CLINICAL CANCER RESEARCH
- Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients
- (2016) Amos Kirilovsky et al. INTERNATIONAL IMMUNOLOGY
- Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases
- (2016) Mübeccel Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Reed-Sternberg cell-derived lymphotoxin- activates endothelial cells to enhance T-cell recruitment in classical Hodgkin lymphoma
- (2014) C. W. Fhu et al. BLOOD
- Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells
- (2014) J. Reichel et al. BLOOD
- Genetic Associations in Classical Hodgkin Lymphoma: A Systematic Review and Insights into Susceptibility Mechanisms
- (2014) K. Kushekhar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Epstein-Barr virus and the pathogenesis of lymphoma
- (2014) Martina Vockerodt et al. JOURNAL OF PATHOLOGY
- The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing
- (2014) Y Liu et al. LEUKEMIA
- Interleukin-21: a double-edged sword with therapeutic potential
- (2014) Rosanne Spolski et al. NATURE REVIEWS DRUG DISCOVERY
- Immunologic pathomechanism of Hodgkin's lymphoma
- (2013) Adam Jona et al. EXPERIMENTAL HEMATOLOGY
- The microenvironment in classical Hodgkin lymphoma: An actively shaped and essential tumor component
- (2013) Yuxuan Liu et al. SEMINARS IN CANCER BIOLOGY
- Hodgkin lymphoma
- (2012) Ralf Küppers et al. JOURNAL OF CLINICAL INVESTIGATION
- Pilot study of vascular health in survivors of Hodgkin lymphoma
- (2012) Daniel A. Mulrooney et al. PEDIATRIC BLOOD & CANCER
- Brentuximab Vedotin (SGN-35)
- (2011) J. Katz et al. CLINICAL CANCER RESEARCH
- MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
- (2011) Christian Steidl et al. NATURE
- TNF superfamily in inflammatory disease: translating basic insights
- (2011) Michael Croft et al. TRENDS IN IMMUNOLOGY
- Tumor Necrosis Factor (TNF) and Lymphotoxin- (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium
- (2010) C. F. Skibola et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Multiplexed Detection and Characterization of Rare Tumor Cells in Hodgkin’s Lymphoma with Multicolor Quantum Dots
- (2010) Jian Liu et al. ANALYTICAL CHEMISTRY
- Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome
- (2010) C. Steidl et al. BLOOD
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
- (2010) Malcolm A. Smith et al. JOURNAL OF CLINICAL ONCOLOGY
- The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape
- (2010) Donatella Aldinucci et al. JOURNAL OF PATHOLOGY
- Pathogenesis of Classical and Lymphocyte-Predominant Hodgkin Lymphoma
- (2009) Roland Schmitz et al. Annual Review of Pathology-Mechanisms of Disease
- IL-21: roles in immunopathology and cancer therapy
- (2009) H. Søndergaard et al. TISSUE ANTIGENS
- Expression and function of T cell homing molecules in Hodgkin’s lymphoma
- (2008) Lee Machado et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group
- (2008) Maura O'Leary et al. SEMINARS IN ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now